Analysed IONIS PHARMACEUTICALS INC (IONS:NASDAQ) News Sources
Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 Readouts
26-05-2026
marketbeat.com
[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
26-05-2026
yahoo.com
Tryngolza shows efficacy in severe hypertriglyceridemia as approval verdicts loom
27-05-2026
clinicaltrialsarena.com
Ionis partner GSK announces bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B
28-05-2026
yahoo.com
Why The Story Around Ionis Pharmaceuticals (IONS) Is Shifting After Fresh Analyst Targets And Guidance
29-05-2026
yahoo.com
GSK’s hepatitis B drug touts functional curative potential in double Phase III win
29-05-2026
clinicaltrialsarena.com
What is the current price of IONIS PHARMACEUTICALS INC (IONS:NASDAQ)?
The current price of IONIS PHARMACEUTICALS INC (IONS:NASDAQ) is $75.49.
IONIS PHARMACEUTICALS INC (IONS:NASDAQ) absolute price change since previous trading day?
The absolute price change of IONIS PHARMACEUTICALS INC (IONS:NASDAQ) since the previous trading day is $-1.01.
IONIS PHARMACEUTICALS INC (IONS:NASDAQ) percentage price change since previous trading day?
The percentage price change of IONIS PHARMACEUTICALS INC (IONS:NASDAQ) since the previous trading day is -1.3203%.
What is the most recent average sentiment score for IONIS PHARMACEUTICALS INC (IONS:NASDAQ)?
The most recent average sentiment score for IONIS PHARMACEUTICALS INC (IONS:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for IONIS PHARMACEUTICALS INC (IONS:NASDAQ)?
The most recent sentiment for IONIS PHARMACEUTICALS INC (IONS:NASDAQ) is .
SEC-8K** Filing Available For IONIS PHARMACEUTICALS INC (IONS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.